PM
MGCD

Penbrook Management’s MGC Diagnostics Corporation MGCD Stock Holding History

Penbrook Management’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-58,549
Closed -$741K – 117
2013
Q4 		$741K Buy
+58,549
New +$715K 0.72% 56

Other funds holding MGCD

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
HAMF
Hatteras Alternative Mutual Funds Raleigh, North Carolina $221M AUM 39.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Penbrook Management's MGCD Position: Q1 2014 in Review

Penbrook Management sold out of MGC Diagnostics Corporation (MGCD) in Q1 2014, closing a stake of 58,549 shares — an estimated $741K sold.

Penbrook Management first reported a position in MGCD in Q4 2013 and held it in 1 quarter. The position peaked at $741K in Q4 2013. 21 funds tracked by Wall St. Rank hold MGCD as of Q1 2014.

  • Penbrook Management reported no remaining MGC Diagnostics Corporation position as of Q1 2014 after selling out during the quarter.
  • Penbrook Management sold 58,549 MGC Diagnostics Corporation shares in Q1 2014, an estimated $741K.
  • Penbrook Management first reported a position in MGC Diagnostics Corporation in Q4 2013 and held it in 1 quarter.
  • Penbrook Management's MGC Diagnostics Corporation position peaked at $741K in Q4 2013.
  • 21 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2014.

Based on Penbrook Management's 13F filing for Q1 2014, filed 2 May 2014.